ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Gavin J. Murphy
Alan J. Bryan
Gianni D. Angelini
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Murphy, G. J.
Right arrow Articles by Angelini, G. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Murphy, G. J.
Right arrow Articles by Angelini, G. D.

Ann Thorac Surg 2004;78:1861-1867
© 2004 The Society of Thoracic Surgeons


REVIEW

Hybrid Coronary Revascularization in the Era of Drug-Eluting Stents

Gavin J. Murphy, FRCS, Alan J. Bryan, FRCS, Gianni D. Angelini, FRCS*

Bristol Heart Institute, University of Bristol, Bristol, United Kingdom

Accepted for publication July 14, 2004.

* Address reprint requests to Prof Angelini, Bristol Heart Institute, Bristol Royal Infirmary, Bristol BS2 8HW, UK (E-mail: g.d.angelini{at}bristol.ac.uk).

Left internal mammary artery to left anterior descending coronary artery bypass grafting integrated with percutaneous coronary angioplasty (hybrid procedure) offers multivessel revascularization with minimal morbidity in high-risk patients. This is caused in part by the avoidance of cardiopulmonary bypass–related morbidity and manipulation of the aorta coupled with minimally invasive techniques. Hybrid revascularization is currently reserved for particularly high-risk patients or those with favorable anatomic variants however, largely because of the emergence of off-pump coronary artery bypass grafting, which permits more complete multivessel revascularization, with low morbidity in high-risk groups. The wider introduction of hybrid revascularization is limited chiefly by the high number of repeat interventions compared with off-pump coronary artery bypass grafting, which occurs because of the target vessel failure rate of percutaneous coronary intervention. Other demerits are the costs and logistic problems associated with performing two procedures with differing periprocedural management protocols. Recently, drug-eluting stents have reduced the need for repeat intervention after percutaneous coronary intervention, and this has raised the possibility that the results of hybrid revascularization may now equal or even better those of off-pump coronary artery bypass grafting. Although undoubtedly effective at reducing in-stent restenosis, drug-eluting stents will not address the issues of incomplete revascularization or the logistic problems associated with hybrid. Uncertainty regarding the long-term effectiveness of drug-eluting stents in many patients, as well as their high cost when compared with those of off-pump coronary artery bypass grafting surgery, also militates against the wider introduction of hybrid revascularization.




This article has been cited by other articles:


Home page
Eur. J. Cardiothorac. Surg.Home page
J. H. Shim, W.-M. Jo, W. J. Chung, and J. H. Chung
Unexpected stent thrombus after minimally invasive direct coronary artery bypass in hybrid re-vascularisation
Eur. J. Cardiothorac. Surg., August 1, 2009; 36(2): 419 - 421.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
D. X. Zhao, M. Leacche, J. M. Balaguer, K. D. Boudoulas, J. A. Damp, J. P. Greelish, J. G. Byrne, and the Writing Group on behalf of the Cardiac Surgery
Routine intraoperative completion angiography after coronary artery bypass grafting and 1-stop hybrid revascularization results from a fully integrated hybrid catheterization laboratory/operating room.
J. Am. Coll. Cardiol., January 20, 2009; 53(3): 232 - 241.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
D. M. Holzhey, S. Jacobs, M. Mochalski, D. Merk, T. Walther, F. W. Mohr, and V. Falk
Minimally Invasive Hybrid Coronary Artery Revascularization
Ann. Thorac. Surg., December 1, 2008; 86(6): 1856 - 1860.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
B. Kiaii, R. S. McClure, P. Stewart, R. Rayman, S. A. Swinamer, Y. Suematsu, S. Fox, J. Higgins, C. Albion, W. J. Kostuk, et al.
Simultaneous integrated coronary artery revascularization with long-term angiographic follow-up
J. Thorac. Cardiovasc. Surg., September 1, 2008; 136(3): 702 - 708.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. T.L. Ong and P. W. Serruys
Complete Revascularization: Coronary Artery Bypass Graft Surgery Versus Percutaneous Coronary Intervention
Circulation, July 18, 2006; 114(3): 249 - 255.
[Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
T. A. Vassiliades Jr, J. S. Douglas, D. C. Morris, P. C. Block, Z. Ghazzal, S. T. Rab, and C. U. Cates
Integrated coronary revascularization with drug-eluting stents: Immediate and seven-month outcome
J. Thorac. Cardiovasc. Surg., May 1, 2006; 131(5): 956 - 962.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2004 by The Society of Thoracic Surgeons.